000 | 01698 a2200481 4500 | ||
---|---|---|---|
005 | 20250517022338.0 | ||
264 | 0 | _c20150807 | |
008 | 201508s 0 0 eng d | ||
022 | _a1432-0843 | ||
024 | 7 |
_a10.1007/s00280-015-2722-y _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMuzzio, Miguel | |
245 | 0 | 0 |
_aPlasma pharmacokinetics of the indenoisoquinoline topoisomerase I inhibitor, NSC 743400, in rats and dogs. _h[electronic resource] |
260 |
_bCancer chemotherapy and pharmacology _cMay 2015 |
||
300 |
_a1015-23 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aBenzodioxoles _xadministration & dosage |
650 | 0 | 4 | _aDogs |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aInfusions, Intravenous |
650 | 0 | 4 | _aInjections, Intravenous |
650 | 0 | 4 |
_aIsoquinolines _xadministration & dosage |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aRandom Allocation |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Inbred F344 |
650 | 0 | 4 |
_aTopoisomerase I Inhibitors _xadministration & dosage |
700 | 1 | _aHu, Shu-Chieh | |
700 | 1 | _aHolleran, Julianne L | |
700 | 1 | _aParise, Robert A | |
700 | 1 | _aEiseman, Julie L | |
700 | 1 | _aYellow-Duke, Archibong E | |
700 | 1 | _aCovey, Joseph M | |
700 | 1 | _aGlaze, Elizabeth R | |
700 | 1 | _aEngelke, Kory | |
700 | 1 | _aEgorin, Merrill J | |
700 | 1 | _aMcCormick, David L | |
700 | 1 | _aBeumer, Jan H | |
773 | 0 |
_tCancer chemotherapy and pharmacology _gvol. 75 _gno. 5 _gp. 1015-23 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00280-015-2722-y _zAvailable from publisher's website |
999 |
_c24713162 _d24713162 |